Domov › Kronična bolezen ledvic › Ohio
Klinične študije za Kronična bolezen ledvic v Ohio
15 študij za Kronična bolezen ledvic išče udeležence na lokacijah v Ohio.
Mesta v Ohio
Uradno besedilo študije (angleško)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #20, Cleveland
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07268638A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Canton
- Research Site, Cincinnati
- Research Site, Cincinnati
- in še 3
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Cincinnati
- Research Site, Cincinnati
Vključevanje udeležencevFaza 3
Starost 18–99 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07624305Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Cincinnati Childrens Hospital MC, Cincinnati
Vključevanje udeležencevFaza 3
Starost 2–18 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07498335A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07107945A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Cincinnati
- Research Site, Maumee
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07753993Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
- Cleveland Clinic, Cleveland
Vključevanje udeležencevOpazovalna študija
Starost 18–65 · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT06694558BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
- Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT06741072Ferric Citrate and Chronic Kidney Disease in Children
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's, Columbus
Vključevanje udeležencevFaza 2
Starost 6–18 · Vsi spoli · Posodobljeno 17. apr. 2026 · NCT04741646A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Akron Nephrology Associates, Inc., Akron
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 17. apr. 2026 · NCT03619850Kidney Precision Medicine Project
- Cleveland Clinic, Cleveland
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 14. apr. 2026 · NCT04334707A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Cleveland Clinic Foundation, Cleveland
Vključevanje udeležencevFaza 3
Starost 0–18 · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT03633708Transformative Research in Diabetic Nephropathy
- Ohio State University, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18–100 · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT02986984A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- US Renal Care - Alexis, Toledo
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 29. jan. 2026 · NCT06933472Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.